tetano
Editor, Senior Moderator
Emerg Infect Dis. 2011 Nov;17(11):2043-6.
Influenza B viruses with mutation in the neuraminidase active site, north Carolina, USA, 2010-11.
Sleeman K, Sheu TG, Moore Z, Kilpatrick S, Garg S, Fry AM, Gubareva LV.
Source
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that may reduce susceptibility to oseltamivir and the investigational drug peramivir but not to zanamivir.
PMID:
22099093
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22099093
Influenza B viruses with mutation in the neuraminidase active site, north Carolina, USA, 2010-11.
Sleeman K, Sheu TG, Moore Z, Kilpatrick S, Garg S, Fry AM, Gubareva LV.
Source
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that may reduce susceptibility to oseltamivir and the investigational drug peramivir but not to zanamivir.
PMID:
22099093
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22099093